Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan in Cilostazol-Induced Headache
NCT02486276Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jun 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine comparing Sumatriptan with Placebo (2 arms). Primary endpoint: Difference in median headache score at 2 hours. Started Jun 2015; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02486276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486276.